| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 17. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | remimazolam (Byfavo®) |
| Formulation | 20 mg powder for solution for injection |
| Reference number | 1162 |
| Indication | Use in adults for procedural sedation |
| Company | Paion UK Ltd |
| BNF chapter | Anaesthesia |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 14/04/2021 |